Unlocking the True Potential of Decentralized Research with UBC & Seqster
Decentralization of clinical research has been discussed and promised for some time however reliance upon sites still presents limitations, including the need to locate appropriate sites for recruiting a suitable patient population, the need for research staff to dedicate time to manual data abstraction, and the costs associated with each of these challenges. It’s time to disrupt the fragmented EHR landscape with patient-mediated medical record release to drive cost savings, lower burden on health care providers, eliminate data latency and increase data quality.
The key to unlocking a hybrid or fully decentralized study design that will optimize your research objective(s) is in direct-to-patient research. Greatly minimizing, or even eliminating, the necessity of a research site is a tremendous feat, but how do you easily obtain longitudinal medical records in a standardized, fit-for-research format?
Seqster’s proprietary operating system integrates with EHR providers nationwide to standardize, harmonize, and visualize health data regardless of the EHR source. Patients can be recruited into any study directly or via sites. They are then able to seamlessly aggregate their comprehensive healthcare data in one secure location – for their own benefit as well as for any study they opt into.
Learn how patient-mediated medical record acquisition can fundamentally optimize study designs. By opening the possibility for truly decentralized research, you can generate powerful evidence of your product’s safety, effectiveness, and value with tremendous efficiency. Explore the details and practical possibilities with UBC’s VP of Real World Evidence Aaron Berger and Seqster’s CEO and Co-Founder Ardy Arianpour during this webinar.
Presented by

Aaron Berger,
VP RWE, UBC
Mr. Berger joined the UBC team in 2003 and has since served in a range of diverse roles leveraging global capabilities in the execution of peri- and post-marketing product development programs and Real World Evidence generation. Mr. Berger supports the development of RWD / RWE architectures and solutions to drive greater insight into the safety profile and value proposition of medicines.

Andy Arianpour,
CEO & Co-Founder, Seqster
Ardy Arianpour is CEO & Co-Founder of Seqster, a leading patient-centric healthcare technology company that enables organizations to drive efficient healthcare. Ardy received his BS in Biological Sciences from UC Irvine and an MBA from Marshall Goldsmith School of Management. He was awarded MM&M Top 40 Healthcare Transformer, SDBJ 40 under 40, and Top Tech Awards 2021.